New nano drug could stop chemo nausea in its tracks
NCT ID NCT07246070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new form of the drug megestrol acetate (nano-crystalline) combined with a standard anti-nausea medicine to prevent nausea and vomiting caused by chemotherapy. It involves 127 people with stomach cancer who are starting their first chemotherapy. The goal is to see if this combination works better than the current standard treatment (dexamethasone plus the same anti-nausea medicine) over a 21-day period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.